These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 1008991)
1. Prognostic value of peripheral lymphocyte count in hormone therapy of advanced breast cancer. Franks CR; Williams Y Br J Cancer; 1976 Dec; 34(6):641-4. PubMed ID: 1008991 [TBL] [Abstract][Full Text] [Related]
2. Sex-hormone-binding globulin predicts response of breast cancer to hormone therapy. Murayama YI; Utsunomiya J; Asano KI Lancet; 1977 Dec 24-31; 2(8052-8053):1356. PubMed ID: 74760 [No Abstract] [Full Text] [Related]
3. The response to endocrine therapy in patients with advanced breast cancer in Great Britain and Japan. Hayward JL; Rubens RD; Sexton S; Tong D; Bulbrook RD; Kumaoka S; Abe O; Takatani O; Yoshida M; Miura S; Murai H; Ariyoshi Y Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1197-204. PubMed ID: 6891657 [TBL] [Abstract][Full Text] [Related]
4. [Hormone therapy in terminal breast cancer--with reference to the effect of androgens and estrogens]. Sakauchi N; Takatani O; Abe Y; Kusama M; Kumaoka S Gan No Rinsho; 1967 Oct; 13(10):834-41. PubMed ID: 5627462 [No Abstract] [Full Text] [Related]
5. The treatment of advanced breast cancer by hormone therapy. DOUGLAS M Br J Cancer; 1952 Mar; 6(1):32-45. PubMed ID: 14925266 [No Abstract] [Full Text] [Related]
6. Peripheral blood lymphocyte counts and survival in breast cancer. Fodor J Neoplasma; 1976; 23(3):311-3. PubMed ID: 958532 [TBL] [Abstract][Full Text] [Related]
7. Hormone treatment of breast cancer. Segaloff A JAMA; 1975 Dec; 234(11):1175-7. PubMed ID: 1242442 [TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of peripheral lymphocyte counts in patients with breast carcinoma. Papatestas AE; Lesnick GJ; Genkins G; Aufses AH Cancer; 1976 Jan; 37(1):164-8. PubMed ID: 1247952 [TBL] [Abstract][Full Text] [Related]
9. [Considerations on hormone therapy of cancer of the breast]. Stoppa IM Minerva Radiol; 1967 Oct; 12(10):372-4. PubMed ID: 4180322 [No Abstract] [Full Text] [Related]
10. [Results of hormonal treatment of breast cancer with special reference to preventive therapy]. Schmidt H; Bauer R Strahlentherapie; 1968 Sep; 136(3):259-62. PubMed ID: 5685748 [No Abstract] [Full Text] [Related]
11. Palliative hormone therapy of advanced mammary cancer; review of 106 patients studied in seven years. FOSS GL Lancet; 1956 May; 270(6924):651-6. PubMed ID: 13320836 [No Abstract] [Full Text] [Related]
12. [Data on the so-called "aimed hormone therapy" of breast cancer]. Vághy IM; Ladányi J; Matolay G Orv Hetil; 1968 Jan; 109(3):130-2. PubMed ID: 5675681 [No Abstract] [Full Text] [Related]
13. Usefulness of lymphocyte-to-monocyte, neutrophil-to-monocyte and neutrophil-to-lymphocyte ratios as prognostic markers in breast cancer patients treated with neoadjuvant chemotherapy. Marín Hernández C; Piñero Madrona A; Gil Vázquez PJ; Galindo Fernández PJ; Ruiz Merino G; Alonso Romero JL; Parrilla Paricio P Clin Transl Oncol; 2018 Apr; 20(4):476-483. PubMed ID: 28785911 [TBL] [Abstract][Full Text] [Related]
14. Proceedings: Clinical value of predictive tests for advanced breast cancer. Engelsman E Br J Cancer; 1974 Aug; 30(2):189-90. PubMed ID: 4370884 [TBL] [Abstract][Full Text] [Related]
15. [Additional hormone therapy in breast cancer]. Viladiu Quemada P Rev Clin Esp; 1974 Mar; 132(5):467-72. PubMed ID: 4831279 [No Abstract] [Full Text] [Related]
16. [Directed hormone therapy of malignant tumors of the breast]. Vepkhvadze KF; Mardakhiashvili ShI; Pavlov KA Vestn Khir Im I I Grek; 1968 May; 100(5):18-21. PubMed ID: 5660824 [No Abstract] [Full Text] [Related]